Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study
Oncology Letters · 22.10.2026 · 32 (6) · 1-8
DOI: 10.3892/ol.2026.15917 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Oncology Letters, online erschienen am 22.10.2026. Verfasst von Atsuto Katano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The incidence of prostate adenocarcinoma (PCa) increases with age. Stereotactic body radiotherapy (SBRT) is a curative option; however, the evidence in elderly patients remains limited. This single-institution retrospective cohort study included consecutive patients aged ≥80 years with localized PCa treated with definitive SBRT between May 2016 and June 2023. SBRT was delivered in five fractions with a total dose of 36.25-45.00 Gy. A total of 118 patients with a median age of 82 years (range, 80-93 years) were included. Risk stratification identified three low-risk, 15 favorable intermediate-risk, 32 unfavorable intermediate-risk, 48 high-risk and 20 very high-risk patients. With a median follow-up of 47.7 months, there were seven deaths from any cause and nine biochemical recurrences, with no PCa-related deaths observed. The 3- and 5-year overall survival rates were 99.1 and 94.2%, respectively, whereas the 3- and 5-year biochemical progression-free survival rates were 94.5 and 83.2%, respectively. No acute genitourinary or gastrointestinal toxicities of grade 3 or higher were observed. Late grade 3 genitourinary and gastrointestinal toxicities were each observed in three patients, with no grade higher than 3 events. Definitive prostate SBRT achieved favorable survival outcomes with acceptable toxicity in carefully selected octogenarians and nonagenarians, supporting its feasibility as a curative-intent treatment option in this elderly population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Zitieren
APA
Katano, A., & Yamashita, H. (2026). Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study. Oncology Letters, 32(6), 1-8. https://doi.org/10.3892/ol.2026.15917
Vancouver
Katano A, Yamashita H. Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study. Oncology Letters. 2026;32(6):1-8. doi:10.3892/ol.2026.15917
BibTeX
@article{Katano2026,
author = {Katano, Atsuto and Yamashita, Hideomi},
title = {Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {6},
pages = {1--8},
doi = {10.3892/ol.2026.15917}
}
EUVIMED